Transmedics Group Inc expected to post earnings of 26 cents a share - Earnings Preview

TransMedics

06/05/2025 23:07

Transmedics Group Inc TMDX.OQ TMDX.O is expected to show a rise in quarterly revenue when it reports  results on May 8 for the period ending March 31 2025

The Andover Massachusetts-based  company is expected to report a 27.7% increase in revenue to $123.66 million from $96.85 million a year ago, according to the mean estimate from 9 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Transmedics Group Inc is for earnings of 26 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Transmedics Group Inc is $112.50​, above​ its last closing price of $93.38. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
0.20
0.16
0.19
Beat
18.8
Sep. 30 2024
0.29
0.29
0.12
Missed
-59.1
Jun. 30 2024
0.20
0.21
0.35
Beat
66.7​
Mar. 31 2024
-0.04
-0.04
0.35
Beat
975
​​Dec. 31 2023
-0.03
-0.06
0.12
Beat
293.5
Sep. 30 2023
-0.16
-0.16
-0.78
Missed
-382.5​
Jun. 30 2023
-0.11
-0.13
-0.03
Beat
76.9
Mar. 31 2023
-0.21
-0.25
-0.08
Beat
67.5

This summary was machine generated May 6 at 22:07 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)